Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.
Open Access
- 1 June 1987
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 79 (6) , 1788-1797
- https://doi.org/10.1172/jci113020
Abstract
We reported that aspirin (ASA) abnormally prolongs bleeding time (BT) in uremia. The present study was designed to investigate whether the abnormally prolonged post-ASA BT in uremia is due to different ASA pharmacokinetics and bioavailability that might be a consequence of uremic condition, platelet cyclooxygenase is peculiarly sensitive to ASA in uremia, and ASA affects primary hemostasis in uremia by a mechanism independent of cyclooxygenase inhibition. Our results showed that in patients with uremia, but not in normal subjects, ASA markedly prolongs the BT. This effect is transient and depends on the presence of ASA in the blood. The observed differences in ASA kinetic parameters are not an explanation of the exaggerated effect of ASA on primary hemostasis in uremia. The sensitivity of platelet cyclooxygenase to ASA inhibition is comparable in uremics and in normal subjects. The temporal dissociation between ASA-induced prolongation of BT and the effect on platelet thromboxane A2 generation suggests that ASA inhibits platelet function in uremia by a mechanism distinct from cyclooxygenase blocking. This possibility is strengthened by the observation that ibuprofen at a dose that fully inhibits platelet cyclooxygenase activity does not significantly prolong BT.This publication has 26 references indexed in Scilit:
- Conjugated Estrogens for the Management of Bleeding Associated with Renal FailureNew England Journal of Medicine, 1986
- MODERATE DOSES OF ASPIRIN AND RISK OF BLEEDING IN RENAL FAILUREThe Lancet, 1986
- Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.Circulation, 1985
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Aspirin as an Antithrombotic MedicationNew England Journal of Medicine, 1983
- Reduced Platelet Thromboxane Formation in Uremia. EVIDENCE FOR A FUNCTIONAL CYCLOOXYGENASE DEFECTJournal of Clinical Investigation, 1983
- Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaNew England Journal of Medicine, 1983
- Ethanol Potentiation of Aspirin-Induced Prolongation of the Bleeding TimeNew England Journal of Medicine, 1982
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- Protein Binding of Drugs in Plasma from Patients with Acute Renal FailureActa Pharmacologica et Toxicologica, 1973